Clinical trial of the efficacy of new S-1 schedule (administered 14days followed by 7 days rest) for metastatic or recurrent breast cancer
Latest Information Update: 03 Sep 2013
At a glance
- Drugs Gimeracil/oteracil/tegafur (Primary)
- Indications Breast cancer
- Focus Therapeutic Use
- Acronyms KBCOG13
- 03 Sep 2013 New trial record